ShortageWatch RxUS drug shortage tracker, built on FDA data

← All shortages

Irinotecan Hydrochloride Injection shortage

To Be Discontinued  2 presentations · 1 manufacturers · first FDA posting 2026-02-24 · last update 2026-02-24

Manufacturers: Ingenus Pharmaceuticals LLC

Stated reasons (per FDA): Not stated

📬 Get weekly shortage updates by email

Presentations

PresentationManufacturerStatusReasonNotes (FDA)Dates
Irinotecan Hydrochloride, Injection, 40 mg/2 mL (NDC 50742-401-02)Ingenus Pharmaceuticals LLCTo Be Discontinued
 —A business decision was made to discontinue manufacture of the drug.Posted 02/24/2026
Updated 02/24/2026
Discontinued 02/24/2026
Irinotecan Hydrochloride, Injection, 100 mg/5 mL (NDC 50742-402-05)Ingenus Pharmaceuticals LLCTo Be Discontinued
 —A business decision was made to discontinue manufacture of the drug.Posted 02/24/2026
Updated 02/24/2026
Discontinued 02/24/2026

Source: FDA Drug Shortages Database · raw openFDA records

Get the weekly shortage roundup: a free email of FDA shortage changes (open form)